Element Boulder
Louisville, Colorado, 80027, United States
NCT Number: NCT07147907
The goal of this clinical trial is to test how accurately a new chest-worn device called the Perin Health Patch measures breathing rate in adults aged 22 and older. The main question it aims to answer is:
How accurately does the Perin Health Patch measure breathing rate compared to a standard medical device that measures carbon dioxide in exhaled breath?
Participants will:
* Wear the Perin Health Patch on their chest during the study session * Breathe through a mouthpiece or nose tube connected to a standard breathing monitor * Follow guided breathing exercises at different speeds (from very slow to fast breathing) using a breathing app * Sit and lie down in different positions during the measurements * Complete the study in one visit lasting about 1-2 hours
The study will include both healthy adults and people with conditions like asthma, COPD, heart failure, diabetes, high blood pressure, or obesity to test how well the device works for different types of people. Researchers will compare the breathing rate numbers from the new chest patch to the standard medical device to see if the patch is accurate enough for medical use.
Looking for future studies?
Notify Me22 year and older
All sexes
Observational
Louisville, Colorado, 80027, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Perin Health Patch is a non-invasive, chest-worn wearable device designed to continuously monitor physiological signals, including respiratory rate and other health metrics. In this study, the device will be evaluated for its ability to accurately measure respiratory rate during controlled breathing exercises in healthy adult volunteers. The respiratory rate values recorded by the Perin Health Patch will be compared against respiratory rate measurements obtained via manually scored end tidal carbon dioxide (EtCO2) waveforms from a GE Datex-Ohmeda monitor, following Element Laboratory protocols aligned with clinical validation standards. The intervention in this study is limited to the application and use of the device for data collection during controlled respiratory rate conditions, where participants perform paced breathing exercises at various rates (5-50 breaths per minute) using a breathing app while positioned sitting or lying supine.
Time frame: During a single in-lab session lasting approximately 1 hour per participant
The primary outcome is the accuracy of respiratory rate (RR) values reported by the Perin Health Patch compared to respiratory rate measured by manually scored end tidal carbon dioxide (EtCO₂) waveforms from a GE Datex-Ohmeda monitor. Accuracy will be assessed using mean absolute error (MAE), accuracy root mean square (ARMS), bias (mean difference), and standard deviation. Measurements will be collected during multiple stable respiratory rate plateaus (approximately 5-50 breaths per minute) achieved through paced breathing exercises. Each comparison will be made during 60-second intervals at steady-state conditions, with the reference EtCO₂ waveform scored by blinded reviewers counting respiratory peaks per minute.
Perin Health Devices
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06140433
Heart Rate, Respiration Rate
Eindhoven, North Brabant, Netherlands
View Trial DetailsNCT07147920
ECG, Electrocardiography
Woodland Hills, California, United States
View Trial DetailsNCT04026555
Clinical Deterioration, Disease Attributes
New York, United States
View Trial DetailsNCT03579641
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Birmingham, Alabama, United States
View Trial Details